Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2018, 6(3), 53-54
DOI: 10.12691/AJMCR-6-3-4
Case Report

Atypical Multimetameric Presentation with Paresis of Zoster in an Immunocompromised Patient

Ines Kechaou1, , Imene Boukhris1, Eya Cherif1, Samira Azzabi1, Lamia Ben Hassine1 and Narjess Khalfallah1

1Internal Medicine Department B. Hospital of Charles Nicolle, University of Tunis El Manar, Tunis, Tunisia

Pub. Date: April 25, 2018
Full Text PDF

Cite this paper

Ines Kechaou, Imene Boukhris, Eya Cherif, Samira Azzabi, Lamia Ben Hassine and Narjess Khalfallah. Atypical Multimetameric Presentation with Paresis of Zoster in an Immunocompromised Patient. American Journal of Medical Case Reports. 2018; 6(3):53-54. doi: 10.12691/AJMCR-6-3-4

Abstract

We report an uncommon multimetameric presentation (L3, L4 and L5) of zoster with paresis in a 56-year-old-immunocompromised woman with past history of systemic lupus erythematosus. She was treated previously by immunosuppressive therapy with several infectious complications.

Keywords

herpes zoster virus, immunosuppression, acyclovir

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review. Indian J Dermatol Venereol Leprol. 2018 (8).
 
[2]  Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 Suppl):S3-12.
 
[3]  Schröder C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017;75(3): 207-215.
 
[4]  CEDEF. Infections à herpès virus de l’enfant et de l’adulte immunocompétents : varicelle et zona. Annales de dermatologie et de vénéréologie. 2008; 135S, F25-F31.
 
[5]  Chen LK, Arai H, Chen LY, Chou MY, Djauzi S, Dong B. Looking back to move forward: a twenty year audit of herpes zoster in Asia-Pacific. BMC Infectious Diseases. 2017; 17: 213.
 
[6]  Kawajiri S, Momo Tani, Noda K, Fujishima K, Hattori N, Okuma Y. Segmental Zoster Paresis of Limbs. Report of Three Cases and Review of Literature. The Neurologist. 2007; 13(5): 313-17.
 
[7]  Teo HK, Chawla M, Kaushik M. A Rare Complication of Herpes Zoster: Segmental Zoster Paresis. Case Reports in Medicine Volume 2016, Article ID 7827140, 3 pages.
 
[8]  Dayan RR, Peleg R. Herpes zoster- typical and atypical presentations. Postgraduate Medicine. 2017; 129(6): 567-71.
 
[9]  Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep. 2008; 257(RR-5): 1-30.